Animal models are established, important tools for preclinical safety and efficacy testing. Companies are advancing more “humanized” models to better reflect human responses, while at the same time ...

Ernexa Therapeutics reported new preclinical findings showing its ERNA-101 cell therapy candidate achieved complete tumor ...

Zymeworks presents six posters at AACR highlighting advancements in antibody-drug conjugates and T cell engagers, including ZW209's promise in lung cancer. Zymeworks Inc. announced the presentation of ...

Lung cancer remains the leading cause of cancer-related mortality worldwide, underscoring the urgent need for improved therapeutic strategies grounded in ...

Organoids are miniature tissue or organ models formed by stem cells (including pluripotent stem cells, tissue-specific adult ...

Genetically-humanized FcRn mice provide translational pharmacokinetics (PK) and pharmacodynamics (PD) data for antibody-based therapeutics. The image illustrates a therapeutic antibody (blue) adhering ...

At the 2026 AngloNordic conference, industry leaders highlighted a major shift toward AI-driven, non-animal testing methods in drug development, with Merck KGaA aiming to replace most animal protocols ...

Previously reported results support continued development of EB-003 for PTSD and other neuropsychiatric conditionsRecent U.S. Executive Order supporting psychedelic-inspired therapies highlights ...

In the UK, there was a case where TGN1412, an immunotherapy under development, triggered a cytokine storm within hours of administration to humans, leading to multiple organ failure. Another example, ...

The "Preclinical Imaging Industry Analysis, Size, Share, Growth, Trends, and Forecast 2026-2033 - (by Product Type, Application, End-User, Geographic Coverage and by Company)" has been added to ...